Ischemia and reperfusion (I/R) injury is associated with extensive loss of cardiac myocytes. Bnip3 is a mitochondrial proapoptotic Bcl-2 protein which is expressed in the adult myocardium. To investigate if Bnip3 plays a role in I/R injury, we generated a TAT-fusion protein encoding the carboxyl terminal transmembrane deletion mutant of Bnip3 (TAT-Bnip3DTM) which has been shown to act as a dominant negative to block Bnip3-induced cell death. Perfusion with TAT-Bnip3DTM conferred protection against I/R injury, improved cardiac function, and protected mitochondrial integrity. Moreover, Bnip3 induced extensive fragmentation of the mitochondrial network and increased autophagy in HL-1 myocytes. 3D rendering of confocal images revealed fragmented mitochondria inside autophagosomes. Enhancement of autophagy by ATG5 protected against Bnip3-mediated cell death, whereas inhibition of autophagy by ATG5K130R enhanced cell death. These results suggest that Bnip3 contributes to I/R injury which triggers a protective stress response with upregulation of autophagy and removal of damaged mitochondria.
Myocardial ischemia and reperfusion (I/R) triggers cell death via both necrosis and apoptosis. Irreversible loss of cardiac myocytes may lead to reduced ability to sustain contractile function and progression to heart failure. Necrosis is characterized by swelling of the cell and its organelles, and disruption of the cell membrane. 1 Release of intracellular components into the surrounding tissue leads to activation of an inflammatory response and can cause damage to neighboring cells. In contrast, apoptosis is a highly regulated, energy-dependent cell death program, which leads to elimination of the cell without inducing an inflammatory response. Apoptosis has been implicated in the pathogenesis of several cardiovascular diseases, including myocardial infarction 2 and congestive heart failure. 3 Even though it is clear that loss of cardiac myocytes after I/R contributes to the decline of ventricular function and mortality, the relative contribution of apoptotic versus necrotic cell death are a subject of much debate. An increased understanding of the signaling pathways that are activated during I/R is important to the development of effective therapies.
Bnip3 is a member of the 'BH3-only' subfamily of proapoptotic Bcl-2 family proteins. The BH3 domain is essential for the cell death activity of these proteins, as well as for mediating heterodimerization with anti-or proapoptotic proteins which regulate cell death. 4 Conflicting reports indicate that the apoptotic effects of Bnip3 either depend upon 5 or are independent of the BH3 domain. 6 Bnip3 is unique in that it possesses a C-terminal transmembrane domain that is required for mitochondrial targeting as well as its apoptotic function. 5, 7 Although Bnip3 mRNA can be detected in multiple organs, 7 its physiological function is unknown. Elevated Bnip3 protein levels have been observed in vivo in an animal model of chronic heart failure. 8 Moreover, Bnip3 expression has been reported to be upregulated in neonatal myocytes subjected to hypoxia resulting in mitochondrial dysfunction and subsequent cell death [8] [9] [10] Bnip3 has been demonstrated to induce both necrotic and apoptotic cell death. 10, 11 Recently, upregulation of Bnip3 was reported to correlate with the induction of autophagy in malignant glioma cells. 12 Autophagy plays an important role in cellular homeostasis and is the process by which cells recycle cytoplasm and dispose of excess or damaged organelles. Autophagy also plays an important role in the cellular response to stress and can be upregulated by changes in environmental conditions such as nutrient deprivation. 13 Autophagy has been implicated to play a role in cancer, 14 cardiomyopathy, 15 and neurodegenerative diseases. 16 In the present study, we have examined the role of the mitochondrial proapoptotic protein Bnip3 in I/R injury. We provide evidence that Bnip3 contributes to I/R injury in the ex vivo heart. Moreover, we report that simulated I/R leads to Bnip3-mediated upregulation of autophagy in HL-1 cardiac myocytes and that Bnip3-induced mitochondrial dysfunction correlates with upregulation of autophagy as a protective response to remove damaged mitochondria.
Results
Expression of Bnip3 in adult myocardium. We examined Bnip3 expression in rat hearts and found substantial basal expression of Bnip3 in the adult myocardium, whereas Bnip3 was undetectable in neonatal cardiac myocytes under normal conditions (Figure 1a ). Since Bnip3 has been reported to be induced by hypoxia in neonatal cardiac myocytes, 8, 10 we investigated whether Bnip3 expression increased in hearts subjected to I/R. We found no apparent change in the expression of Bnip3 protein after 30 min of ischemia and 120 min of reperfusion compared to control perfused hearts or freshly isolated nonperfused hearts (Figure 1b) . Furthermore, subcellular fractionation experiments revealed that Bnip3 was exclusively associated with the mitochondria-enriched heavy membrane fraction (Figure 1c) . The subcellular localization of Bnip3 did not change in the cells after I/R (data not shown). To investigate whether Bnip3 is integrated into the mitochondrial membrane, we performed alkali extraction of proteins from mitochondria isolated from the heart. Bnip3 remained tightly associated with the mitochondrial membrane fraction following alkali treatment (Figure 1d ). Bak and Bax were analyzed in parallel as controls. Bak, an integral mitochondrial membrane protein, was also resistant to treatment and remained associated with the membranes after alkaline incubation. In contrast, Bax was only loosely attached to mitochondria under normal conditions and most of Bax was lost during the treatment. These results indicate that Bnip3 exists as an integral mitochondrial membrane protein in the adult myocardium that is inactive in the absence of a death signal. The basis for Bnip3 inactivation is unknown at present.
Bnip3 in ischemia/reperfusion injury. We have established a technique of TAT protein transduction into isolated perfused hearts where linkage of the 11-amino-acid transduction domain of HIV TAT to a protein allows it to be readily transduced into cells in the heart. 17, 18 To determine whether Bnip3 plays a role in mediating I/R injury in the heart, we generated a TAT-fusion protein encoding the carboxyl terminal transmembrane deletion mutant of Bnip3 (TATBnip3DTM) which has been shown to act as a dominant negative to block Bnip3-induced cell death. 8, 10 Western blot analysis of heart lysates from hearts perfused with TATBnip3DTM protein demonstrated that the TAT protein was readily taken up by the hearts after 15 min of perfusion (Figure 2a) . Moreover, perfusion with TAT-Bnip3DTM significantly reduced both creatine kinase (CK) release and infarct size in hearts subjected to 30 min of global ischemia and 120 min of reperfusion compared to TAT-b-gal ( Figure  2b and c) . We have previously demonstrated that TAT-b-gal has no effect on CK release and infarct size. 17 I/R injury is associated with increased production of reactive oxygen species (ROS), such as superoxide anion, hydrogen peroxide, and hydroxyl radical. Bnip3 has been reported to increase ROS production when overexpressed in cells. 11 To assess whether the cardioprotective effects of TATBnip3DTM could be attributed to a reduction in the production of ROS, superoxide generation was measured in heart slices obtained after 30 min of ischemia and 15 min of reperfusion. Using dihydroethidium (DHE) staining to detect superoxide production, we found that TATBnip3DTM attenuated superoxide production after I/R, suggesting that increased ROS production is partly due to activated Bnip3 in I/R hearts (Figure 2d ). Perfusion with TAT-Bnip3DTM prior to ischemia also improved functional recovery after I/R compared with TAT-b-gal-perfused hearts (Figure 2e and f).
Bnip3 and apoptosis. Overexpression of Bnip3 leads to loss of mitochondrial membrane potential and opening of the MPTP; both have been linked to the release of cytochrome c from mitochondria. We found that hearts perfused with TAT-Bnip3DTM exhibited reduced cytochrome c and apoptosis-inducing factor (AIF) release after I/R compared to hearts perfused with TAT-b-gal ( Figure 3a) . Next, we investigated whether Bnip3 could directly induce release of proapoptotic factors from mitochondria. Addition of recombinant Bnip3 to purified heart mitochondria resulted in the release of cytochrome c and AIF, whereas Bnip3DTM had no effect (Figure 3b ). Recombinant tBid, the proteolytically activated fragment of Bid, has previously been reported to induce the release of cytochrome c from isolated mitochondria and was used as a positive control. 19 Moreover, recombinant Bnip3DTM directly inhibited Bnip3-mediated cytochrome c and AIF release in vitro.
Next, we examined whether the protective effect of TATBnip3DTM in I/R was mediated by inhibition of apoptosis. Cardiac apoptosis was assessed in control perfused and in hearts perfused with TAT-b-gal or TAT-Bnip3DTM prior to I/R by detection of cleaved (active) caspase-3 and terminal deoxynucleotideyltransferase-mediated dUTP nick end-labeling (TUNEL) of heart sections. Cells with activated caspase-3 were detected in hearts subjected to I/R in the presence of TAT-b-gal, but not in hearts perfused with TAT-Bnip3DTM . Taken together, these data suggest that Bnip3 plays a significant role in I/R-induced cell death by increasing ROS production, and releasing proapoptotic factors such as cytochrome c and AIF which lead to activation of caspases and DNA fragmentation.
Bnip3 and HL-1 cardiac myocytes. To begin defining the molecular mechanism(s) by which Bnip3 mediates cell death during I/R, we turned to a cell culture model using the atrialderived cardiac myocyte cell line HL-1. Overexpression of Bnip3 allowed us to mimic and monitor the effects of I/Rinduced Bnip3 activation in isolation from other molecular events occurring during I/R. To confirm that Bnip3 mediates the same effects in HL-1 myocytes as in the intact heart, we overexpressed the dominant-negative Bnip3DTM prior to simulated I/R (sI/R). We found that overexpression of Bnip3DTM significantly reduced cell death after sI/R in HL-1 cardiac myocytes (Figure 5a ). Similarly, downregulation of Bnip3 by RNA interference inhibited sI/R-mediated cell death, verifying that Bnip3 contributes to cell death in sI/R (Figure 5b and c). Next, we investigated whether Bnip3-mediated cell death in sI/R was caused by activation of caspases. We found that cell death during sI/R was significantly reduced in the presence of the broad spectrum caspase inhibitor, zVAD-fmk ( Figure 5d ). Furthermore, we found that overexpression of Bnip3 in HL-1 myocytes caused a significant increase in cell death which was inhibited in the presence of zVAD-fmk, suggesting that Bnip3-meditated cell death during I/R is mediated through activation of caspases in HL-1 myocytes (Figure 5e ). Nuclear condensation was characteristic of cell death mediated by both sI/R and Bnip3.
Bnip3 and autophagy. Upregulation of autophagy has been reported to occur in a rabbit model of I/R and in chronically ischemic pig myocardium. 20, 21 Many studies have linked dysfunctional mitochondria with upregulation of autophagy. Thus, we speculated that Bnip3-induced mitochondrial damage in I/R might upregulate autophagy in cardiac myocytes. Electron microscopy revealed the presence of autophagic vacuoles, recognized by their double-membrane vacuolar structures, 22 in the myocardium following I/R, with many of the autophagosomes containing mitochondria ( Figure 6A) . Similarly, the presence of autophagosomes was detected by EM in HL-1 cells after sI/R ( Figure 6B ). A characteristic of autophagy is the recruitment of the microtubule-associated protein 1 light chain 3 (LC3) to autophagic vesicles, which can be detected as punctate accumulations of GFP-LC3. 23 Using GFP-LC3 as a specific marker autophagosome formation, we found that control cells transiently transfected with GFP-LC3 showed predominantly a diffuse distribution of green fluorescence, whereas sI/R resulted in increased punctate patterns indicating enhanced formation of autophagosomes ( Figure 6C ). To investigate whether Bnip3 is involved in I/R-induced autophagy, we transfected HL-1 cells with the dominant-negative Bnip3DTM along with GFP-LC3 before sI/R. We found that overexpression of Bnip3DTM significantly reduced upregulation of autophagy in HL-1 myocytes subjected to sI/R ( Figure 6D ). To further investigate the link between I/R-induced autophagy and Bnip3 activation, HL-1 cells were transiently transfected with wild-type Bnip3 or Bnip3DTM and the level of autophagy was assessed under normoxic conditions. As shown in Figure 7 , overexpression of Bnip3 caused significant induction of autophagy compared to control cells. In contrast, Bnip3DTM-transfected cells did not show a significant increase in autophagy (Figure 7b) .
The autophagic response requires delivery of the contents sequestered by the autophagosome to the lysosome, whereupon degradation occurs. 13 To verify that Bnip3-induced upregulation of autophagosomes reflected an increase in autophagic activity, and not a build-up of nonfused autophagosomes, we monitored the activity of the lysosomal compartments in Bnip3-transfected cells by staining cells with Lysotracker Red (LTR). We found colocalization of GFP-LC3 and LTR, indicating fusion between the autophagosome and lysosome, hence functional autophagy (Figure 7c ). We observed no differences in total LTR staining between control and Bnip3-overexpressing cells (data not shown). Also, we noted that the LTR staining was dispersed throughout the cell in acidic lysosomes in control cells, but was more concentrated to regions of high autophagosomal content in Bnip3-overexpressing cells. (Figure 8 ). To examine whether these fragments of mitochondria were sequestered by autophagosomes (mitophagy), we employed laser scanning confocal microscopy of cells expressing mitoDsRed2 (to label mitochondria) and GFP-LC3 (to label autophagosomes). Analysis of generated Z-stacks revealed that extensive mitophagy occurred in Bnip3-cotransfected HL-1 cells, where many GFP-LC3-labeled autophagosomes colocalized with fragmented mitochondria (Figure 9a ). 3D surface rendering of confocal Z-stacks revealed different stages of engulfment of individual mitochondria (Figure 9b ). We did not observe instances of mitophagy in control or Bnip3DTM-transfected cells (data not shown).
Recently, several studies have reported that autophagy may serve as a protective response. 21, 24, 25 Thus, we hypothesized that upregulation of autophagy serves as a protective response against Bnip3-mediated injury likely by sequestering damaged mitochondria. ATG5 is a key molecule involved in autophagy and is essential for formation of autophagosomes. 26 We found that overexpression of ATG5 significantly enhanced induction of autophagy in cells overexpressing Bnip3 compared to Bnip3 alone, and that this enhancement of autophagy correlated with reduction in Bnip3-mediated cell death (Figure 10a and b) . In contrast, ATG5K130R, a dominant negative of ATG5 previously shown to suppress vacuole formation, 27 significantly reduced autophagy and increased Bnip3-mediated cell death (Figure 10a  and b) . Similarly, overexpression of ATG5 enhanced autophagy during sI/R which correlated with reduced cell death, whereas ATGK130R reduced sI/R-induced autophagy while increasing cell death (data not shown). Thus, these data suggest that Bnip3-mediated mitochondrial dysfunction during I/R leads to upregulation of autophagy as a cellular stress response to dispose of damaged mitochondria.
Discussion
The Bcl-2 family members are important regulators of cell death in the myocardium. In the present study, we show that the mitochondrial protein Bnip3, a BH3-only member of the Bcl-2 family, contributes to I/R injury in the myocardium. We found that Bnip3 was expressed at substantial levels the adult myocardium, whereas Bnip3 was undetectable in neonatal cardiac myocytes. It is likely that Bnip3 exists in an inactive conformation in the absence of a death signal. Kubasiak et al. 10 reported that hypoxia induced expression of Bnip3 in neonatal cardiac myocytes, but hypoxia alone did not signal apoptosis. For substantial apoptosis to occur, hypoxia had to be combined with acidosis, suggesting that Bnip3 activity is regulated by intracellular pH. Several studies have reported that the development of intracellular acidosis plays an important role in apoptotic signaling. 28, 29 Ischemia is associated with a drop in intracellular pH from about 7.2 to 6.3, 30 which may be sufficient to activate Bnip3 in the mitochondria. Bnip3DTM has previously been reported to act as a dominant negative in Bnip3-mediated cell death. 8, 10 Accordingly, we examined whether Bnip3DTM could reduce I/R injury in the myocardium. We found that perfusion of hearts with TAT-Bnip3DTM protected against I/R injury as indicated by diminished CK release and infarct size, as well as improved cardiac function. Suppression of apoptosis by Bnip3DTM was confirmed by TUNEL staining and immunostaining for active caspase-3. Since Bnip3DTM does not interact directly with full-length Bnip3, 7 we hypothesize that it acts as a dominantnegative inhibitor of endogenous Bnip3 by competing for some regulatory factor required for Bnip3 activation. Further work will be necessary to establish the mechanism by which Bnip3DTM protects against cell death.
The importance of mitochondria in determining cell viability after I/R has been increasingly recognized in the past few years. Mitochondrial dysfunction disrupts energy production and can trigger apoptosis. Since Bnip3 is localized exclusively to the mitochondria in myocardial cells and causes mitochondrial dysfunction when overexpressed, we speculated that Bnip3 might contribute to I/R injury through activation of the mitochondrial (intrinsic) pathway of apoptosis. Consistent with this, TAT-Bnip3DTM was able to prevent cytochrome c and Role of Bnip3 in ischemia/reperfusion injury A Hamacher-Brady et al AIF release in isolated perfused hearts subjected to I/R, and recombinant Bnip3 directly caused cytochrome c and AIF release from mitochondria. Further investigation of the mechanism of Bnip3-mediated cell death revealed that caspases are involved in cell death induced by Bnip3 in HL-1 cardiac myocytes. Similarly, Regula et al. 8 reported that Bnip3-induced cell death was dependent on caspase activation. However, other studies have reported that overexpression of Bnip3 in cell lines did not induce detectable release of cytochrome c from mitochondria and that Bnip3-mediated cell death occurred through a caspase-independent mechanism. 10, 11 This variation could be due to the differences in the systems used to study Bnip3 or it could reflect cell-specific regulation of Bnip3, including intracellular pH. In this study, we report that autophagy was present in the adult rat myocardium after I/R and that many of the autophagosomes contained mitochondria. Upregulation of autophagy has been reported to serve as a protective response to various stressors including mitochondrial dysfunction. 31, 32 Recently, Yan et al. 21 reported that chronic ischemia led to induction of autophagy in the myocardium. They found that areas in the myocardium with enhanced autophagy had fewer apoptotic cells, suggesting that induction of autophagy leads to inhibition of apoptosis. We have linked Bnip3 to induction of autophagy in I/R. Moreover, we found that overexpression of Bnip3 resulted in extensive fragmentation of the mitochondria and a massive increase in autophagic vacuoles containing fragments of mitochondria in the absence of I/R. It is likely that the fragmented mitochondria may release proapoptotic factors such as cytochrome c which can activate the intrinsic apoptotic pathway. Thus, upregulation of autophagy in response to Bnip3 activation may serve as a protective response by removing harmful and leaky mitochondria, thus preventing activation of apoptosis. Our data demonstrates that enhancing the autophagic process with ATG5 resulted in reduced cell death by Bnip3, whereas reducing autophagy with ATG5K130R produced the opposite effect. In fact, ATG5 overexpression protected against Bnip3-mediated cell death even after 72 h of transfection (data not shown), suggesting that modulation of the autophagic pathway provides to protection over a prolonged period of time. However, although low levels of autophagy may constitute a protective mechanism by removal of damaged mitochondria, excessive autophagy may lead to cell death. Presently, it is unknown what triggers damaged mitochondria to be removed by autophagy. It is not known whether Bnip3 directly induces autophagy or whether autophagy is induced as a consequence of mitochondrial damage caused by Bnip3. Several studies have reported that overexpression of Bnip3 induces cell death through MPTP opening. 8, 10, 11 Thus, it is possible that the MPTP serves as an upstream signal for mitochondrial autophagy in I/R. Similary, Elmore et al. 31 reported that opening of the MPTP triggered autophagy of damaged mitochondria in hepatocytes. The MPTP has also been reported to play a role in I/R injury. Recent studies have reported that preventing MPTP opening protects against I/R injury. 33, 34 Moreover, mice lacking cyclophilin D, a component of the MPTP, are more resistant to I/R injury, whereas transgenic mice overexpressing cyclophilin D exhibited swollen mitochondria and increased spontaneous cell death. 35 This suggests that Bnip3-mediated mitochondrial damage through opening of the MPTP may be the cause of enhanced autophagy.
In this report, we demonstrate that Bnip3 contributes to I/R injury in the heart. Bnip3 causes disruption of mitochondrial integrity, leading to enhanced superoxide production and the release of proapoptotic factors, such as cytochrome c and AIF. Moreover, we show that I/R induces autophagy in a Bnip3-dependent manner. Taken together, these findings implicate Bnip3 as a major contributor to myocardial injury by causing mitochondrial dysfunction, which is associated with upregulation of autophagy as a protective cellular stress response.
Materials and Methods
Recombinant protein expression and purification. TAT-b-gal and TAT-Bnip3DTM fusion proteins were purified as previously described. 17 His-tagged Bnip3 and Bnip3DTM were grown in BL21(DE3) cells (Invitrogen) and expression was induced with 1 mM IPTG for 4 h. The bacteria were resuspended in Native buffer (150 mM NaCl, 1% Tween-20, 50 mM NaH 2 PO 4 , pH 8.0, and complete protease inhibitors (Roche)), followed by sonication on ice. After centrifugation at 20 000 Â g for 20 min, the supernatants were added to columns containing Ni-NTA (Qiagen Inc.). The proteins were eluted with 250 mM imidazole in Native buffer, followed by desalting on PD-10 columns (Amersham-Pharmacia).
Isolation of neonatal cardiac myocytes. Neonatal rat cardiac myocytes were prepared by collagenase digestion as previously described. 28 Cells were plated on gelatin-coated dishes for 24 h.
Langendorff perfusion and ischemia/reperfusion. Hearts from anesthetized male Sprague-Dawley rats (225-250 g) were rapidly excised and cannulated onto the Langendorff perfusion apparatus using a protocol adapted from Tsuchida et al. 36 The hearts were perfused with or without 50 nM TAT protein and subjected to I/R as described. 17 The Creatine Kinase (CK) activity in the coronary effluent was measured using a diagnostic kit (Stanbio Laboratory) and infarct size was measured using triphenyl tetrazolium staining. Superoxide production was assessed via the conversion of DHE to ethidium as described. 37 For hemodynamic measurements, a thin plastic balloon filled with water was inserted into the left ventricle and connected to a pressure transducer (EMKA Technologies).
Immunohistochemistry. After perfusion, hearts were fixed with 4% formaldehyde, embedded, and thin-sectioned, followed by deparaffinization and rehydration. Sections were blocked in 5% goat serum and then incubated overnight at 41C with an antibody against cleaved caspase-3 (Cell Signaling Technology). Nonspecific staining was assessed by omitting the primary antibody. After washing, sections were incubated for 2 h at room temperature with anti-mouse Alexa 594 (Molecular Probes). In situ labeling of fragmented DNA in heart sections was performed using the In Situ Cell Death Detection kit (Roche Applied Science) according to the manufacturer's instructions. Nuclei were counterstained with Hoechst 33342 (Molecular Probes).
Preparation of mitochondria and cytosol and Western blotting. The isolation of mitochondria and cytosol and Western blotting were carried out as previously described. 18 Briefly, ventricles were minced and homogenized by polytron in ice-cold MSE buffer (220 mM mannitol, 70 mM sucrose, 2 mM EGTA, 5 mM MOPS pH 7.4, and 0.2% BSA). The lysates were centrifuged for 10 min at 600 Â g to remove unbroken tissue and nuclei, and the supernatants were centrifuged for 10 min at 3000 Â g to pellet mitochondria. The supernatant was centrifuged for 30 min at 100 000 Â g to obtain cytosol, while the mitochondrial fraction was resuspended in Incubation Buffer containing 180 mM mannitol, 70 mM sucrose, 10 mM KCl, 10 mM MgCl 2 , 1 mM EGTA, 5 mM KH 2 PO 4 , and 10 mM MOPS pH 7.4.
Alkali extraction. Freshly isolated heart mitochondria were resuspended in freshly prepared 0.1 M Na 2 CO 3 (pH 11.5) and incubated for 20 min on ice. The membranes were recovered by centrifugation at 100 000 Â g for 30 min, separated by SDS-PAGE, and analyzed by immunoblotting using an antibody against Bnip3 (Sigma), Bak (G-23, Santa Cruz), or Bax (N-20, Santa Cruz).
Assessment of cytochrome c and AIF release. Heart mitochondria (50 mg) were incubated with vehicle, Bnip3 (1 mg), Bnip3DTM (1 mg), or tBid (100 ng) for 60 min at 301C, and cytochrome c and AIF release was determined by Western blotting as described. 18 Electron microscopy. Hearts were perfused with 4% paraformaldehyde, 1.5% glutaraldehyde in 0.1 M Na cacodylate buffer, postfixed in 1% osmium tetroxide, dehydrated in ethanol, treated in propylene oxide and embedded in EMbed 812/Araldite (Electron Microscopy Sciences, Fort, Washington, PA, USA). HL-1 myocytes were fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer, postfixed in 1% osmium tetroxide, and then treated with 0.5% tannic acid, 1% sodium sulfate, cleared in 2-hydroxypropyl methacrylate and embedded in LX112 (Ladd Research, Williston, VT, USA). Sections were mounted on copper slot grids coated with parlodion and stained with uranyl acetate and lead citrate for examination on a Philips CM100 electron microscope (FEI, Hillsbrough, OR, USA).
Cell culture model of ischemia/reperfusion. Atrial derived HL-1 mouse cardiac myocytes 38 were cultured in Claycomb medium (JRH Biosciences) supplemented with 10% fetal bovine serum, 0.1 mM norepinephrine, 2 mM Lglutamine, 100 U/ml penicillin, 100 U/ml streptomycin, and 0.25 mg/ml amphotericin B. Simulated ischemia was introduced by incubating cells in ischemic buffer (125 mM NaCl, 8 mM KCl, 1.2 mM KH 2 PO 4 , 1.25 mM MgSO 4 , 1.2 mM CaCl 2 , 6.25 mM NaHCO 3 , 20 mM 2-deoxyglucose, 5 mM Na-lactate, 20 mM HEPES, pH 6.6) and placing the dishes in hypoxic pouches (GasPakt EZ, BD Biosciences) for 2 h at 371C. Reperfusion was initiated by changing to Krebs-Henseleit buffer (110 mM NaCl, 4.7 mM KCl, 1.2 mM KH 2 PO 4 , 1.25 mM MgSO 4 , 1.2 mM CaCl 2 , 25mM NaHCO 3 , 15 mM glucose, 20 mM HEPES, pH 7.4).
Short hairpin RNA and cell death. Sequences with 100% homology to mouse Bnip3 were generated using BLOCK-iTt RNAi Designer (Invitrogen). The target sequence TCCAGCCTCCGTCTCTATTTA (78-98) showed no significant homology to other mouse proteins as determined by BLAST analysis. The sequence was used to generate oligonucleotide pairs, and inserted into the pcDNA6.2-GW/EmGFP-miR vector. To control for nonspecific RNAi effects, the construct pcDNA6.2-GW/EmGFP-miR-LacZ was used as a control. The short DNA constructs. EGFP of the vector pEGFP-C1 (Clonetech) was replaced with mCherry, 39 generating the pmCherry-C1 vector. ATG5 was amplified from mouse cDNA by PCR and ligated into pmCherry-C1 vector. The K130R mutation was generated using site-directed mutagenesis as previously described. 27 Quantitation of cell death and autophagy. HL-1 cardiac myocytes were transfected with GFP-LC3 and either pcDNA3.1, Bnip3, or Bnip3DTM using Effectene according to the manufacturer's instruction (Qiagen). The transfection efficiency of HL-1 cells was around 40%. To determine cell death, HL-1 cells were cotransfected with pDsRed2 and pcDNA3.1 or Bnip3DTM. pDsRed2-positive cells were evaluated for cell death 48 h after transfection or 12 h after reperfusion using YoPro1 (Molecular Probes) fluorescence staining as previously described. 40 YoPro-1 is a nuclear dye that only stains permeable cells undergoing apoptosis and is completely excluded from healthy living cells. To quantify autophagy, fixed cells were classified as cells with predominantly diffuse GFP-LC3 fluorescence or punctate GFP-LC3 pattern 48 h after transfection. Cells were observed through a Nikon TE300 fluorescence microscope (Nikon) equipped with a cooled CCD camera (Orca-ER, Hamamatsu). At least 75-150 cells were scored from two replicate dishes in three independent experiments.
Laser scanning confocal microscopy (LSCM). LSCM was performed with a Bio-Rad Radiance 2100 laser scanning confocal microscope (Hercules, CA, USA) using a Â 60 Plan Apo objective (1.4 N.A oil immersion lens; Nikon, Japan), equipped with both a mixed gas Helium-Neon (543 nm) laser and an Argon (488 nm) laser, and operated through Bio-Rad LaserSharp 2000 software. Green and red fluorescence were directed to separate photomultipliers by a 560-nm longpass dichroic reflector through HQ530SP and HQ590/70 emission filters, respectively. The confocal pinholes were configured so as to obtain images of 0.7 mm in the axial dimension and step increments were 0.3 mm.
